The FHU Oncoage had the pleasure to welcome several world leading experts for the Mini Symposium “Update in Lung Cancer Biomarkers” providing novel insights on the development of biomarkers in Lung Cancer.
Pr. Benjamin Besse, Head of the Thoracic Oncology Unit at Gustave Roussy Cancer in Paris and chair of the EORTC Lung Cancer Group provided a fascinating insight on the role of Radon in Lung Cancer development, followed by an intriguing presentation by Dr. Catherine Alix-Panabières, Director of the Laboratory Rare Circulating Human Cells at the CHU of Montpellier, about the importance of circulating tumor cells. The symposium was concluded by Prof. Angel Märten, Global Medical Advisor at Boehringer Ingelheim presenting great work about the importance of uncommon EGFR mutations in lung Cancer and Prof. Albrecht Stenzinger, Head of the IPH Center for Molecular Pathology who highlighted the importance of biomarker development for anti-cancer immunotherapy.
The symposium was concluded by the thesis defense of Simon Heeke, PhD candidate in the team of Pr. Paul Hofman, Director of the FHU Oncoage.